Safety and efficacy of intravenous clevidipine for the perioperative control of acute hypertension

Clinical Medicine Insights: Therapeutics

Volumn 3, Issue , 2011, Pages 503-515

  Murphy, Claire V ^a   Brower, Kristin I ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Calcium channel blocker; Clevidipine; Perioperative hypertension; Surgery

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CLEVIDIPINE; DEXMEDETOMIDINE; ESMOLOL; FENTANYL; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LIDOCAINE; LIPID EMULSION; METOPROLOL; MIDAZOLAM; NICARDIPINE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROPOFOL; REMIFENTANIL; SEVOFLURANE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTERY MUSCLE; BLOOD PRESSURE REGULATION; BRONCHOSPASM; CALCIUM TRANSPORT; CHRONIC HYPERTENSION; CONTINUOUS INFUSION; CYANIDE TOXICITY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FEVER; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG INFUSION; DRUG INTERACTION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SOLUBILITY; DRUG STORAGE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FIRST DEGREE ATRIOVENTRICULAR BLOCK; FLUSHING; HEART ATRIUM FIBRILLATION; HEART RATE; HEART SURGERY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INFUSION RATE; INJECTION SITE PAIN; INSOMNIA; KIDNEY DYSFUNCTION; MEAN ARTERIAL PRESSURE; MORTALITY; MUSCLE SPASM; NAUSEA; NEUROSURGERY; PARESTHESIA; PERIOPERATIVE ACUTE HYPERTENSION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREMEDICATION; RECOMMENDED DRUG DOSE; REFLEX TACHYCARDIA; REVIEW; ROOM TEMPERATURE; SIDE EFFECT; STORAGE TEMPERATURE; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPHYLAXIS; THIOCYANATE TOXICITY; THROMBOPHLEBITIS; VASODILATATION;

EID: 84855269480     PISSN: 1179559X     EISSN: 1179559X     Source Type: Journal    
DOI: 10.4137/CMT.S6250     Document Type: Review

References (48)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. May 21, 2003;289(19): 2560-72.
2. Prys-Roberts C, Meloche R. Management of anesthesia in patients with hypertension or ischemic heart disease. Int Anesthesiol Clin. Winter 1980;18(4):181-217.
3. Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology. Apr 1979;50(4):285-92.
4. Prys-Roberts C, Greene LT, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. Jun 1971;43(6):531-47.
5. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615-27.
6. Desai RG, Muntazar M, Goldberg ME. Strategies for managing periopera-tive hypertension. Curr Hypertens Rep. Jun 2009;11(3):173-7.
7. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the american college of chest physicians and the international society for heart and lung transplantation: endorsed by the heart rhythm society. Circulation. Sep 20, 2005;112(12):e154-235.
8. Fugit MD, Rubal BJ, Donovan DJ. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood fow. J Invasive Cardiol. Feb 2000;12(2):80-5.
9. Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicar-dipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. Oct 2008;107(4):1110-21.
10. Pitt B. Diversity of calcium antagonists. Clin Ther. 1997;19 Suppl A:3-17.
11. Richard S. Vascular effects of calcium channel antagonists: new evidence. Drugs. 2005;65 Suppl 2:1-10.
12. Cleviprex (clevidipine butyrate). Parsipanny, NJ: The Medicines Company; 2008.
13. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. Aug 1, 2009;66(15):1343-52.
14. Levy JH, Mancao M Y, Gitter R, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled effcacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. Oct 2007;105(4):918-25, table of contents.
15. Bailey JM, Lu W, Levy JH, et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology. May 2002;96(5):1086-94.
16. Schwieler JH, Ericsson H, Lofdahl P, Thulin T, Kahan T. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol. Aug 1999;34(2):268-74.
17. Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute postoperative hypertension in cardiac surgery patients: an effcacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg. Jul 2008;107(1):59-67.
18. Ericsson H, Schwieler J, Lindmark BO, Lofdahl P, Thulin T, Regardh CG. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Chirality. 2001;13(3):130-4.
19. Ericsson H, Fakt C, Hoglund L, et al. Pharmacokinetics and pharmacody-namics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol. Mar 1999;55(1):61-7.
20. Ericsson H, Tholander B, Regardh CG. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. Eur J Pharm Sci. Apr 1999;8(1):29-37.
21. Ericsson H, Bredberg U, Eriksson U, Jolin-Mellgard A, Nordlander M, Regardh CG. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology. Apr 2000;92(4):993-1001.
22. Nordlander M, Sjoquist PO, Ericsson H, Ryden L. Pharmacodynamic, phar-macokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev. Fall 2004;22(3):227-50.
23. Haas CE, LeBlanc JM. Acute postoperative hypertension: a review of therapeutic options. Am J Health Syst Pharm. Aug 15, 2004;61(16): 1661-73; quiz 1674-65.
24. Cheung AT. Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg. Mar-Apr 2006;21 Suppl 1:S8-14.
25. Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg. May 2002;94(5):1079-84, table of contents.
26. Weiss SJ, Longnecker DE. Perioperative hypertension: an overview. Coron Artery Dis. May 1993;4(5):401-6.
27. Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, Shires GT. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? Ann Surg. Nov 1990;212(5):567-80.
28. Powroznyk AV, Vuylsteke A, Naughton C, et al. Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. Eur J Anaesthesiol. Sep 2003;20(9):697-703.
29. Bekker A, Didehvar S, Kim S, et al. Effcacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. J Neurosurg Anesthesiol. Oct 2010;22(4): 330-5.
30. Tobias JD, Hoernschemeyer DG. Clevidipine for controlled hypotension during spinal surgery in adolescents. J Neurosurg Anesthesiol. May 26, 2011.
31. Towe E, Tobias JD. Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med. Nov-Dec 2010;25(6):349-52.
32. Meyer T, Tobias JD. Perioperative blood pressure management with cle-vidipine during coiling of cerebral artery aneurysms. Saudi J Anaesth. Jul 2009;3(2):83-6.
33. Erickson AL, DeGrado JR, Fanikos JR. Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. Pharmacotherapy. May 2010;30(5):515-28.
34. Aronson S. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials. Expert Rev Cardiovasc Ther. May 2009;7(5):465-72.
35. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WF. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. Mar 2009;53(3):329-38.
36. Peacock FW, Varon J, Ebrahimi R, Dunbar L, Pollack CV. Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. Congest Heart Fail. Mar 2010;16(2):55-9.
37. Ericsson H, Fakt C, Jolin-Mellgard A, et al. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol. May 1999;47(5):531-8.
38. Ndefo UA, Erowele GI, Ebiasah R, Green W. Clevidipine: a new intravenous option for the management of acute hypertension. Am J Health Syst Pharm. March 1, 2010;67(5):351-60.
39. Zhang JG, Dehal SS, Ho T, et al. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81. Drug Metab Dispos. May 2006;34(5):734-7.
40. Awad AS, Goldberg ME. Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. Vasc Health Risk Manag. 2010;6:457-64.
41. Vincent JL, Berlot G, Preiser JC, Engelman E, Dereume JP, Khan RJ. Intravenous nicardipine in the treatment of postoperative arterial hypertension. J Cardiothorac Vasc Anesth. Apr 1997;11(2):160-4.
42. Orlowski JP, Shiesley D, Vidt DG, Barnett GH, Little JR. Labetalol to control blood pressure after cerebrovascular surgery. Crit Care Med. Aug 1988; 16(8):765-8.
43. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Comprehensive heart failure practice guideline. J Card Fail. June;16(6):e1-194.
44. Cardene IV (nicardipine). Bedminister, NJ: EKR Therapeutics; 2008.
45. Nitropress (sodium nitroprusside). Lake Forest, IL: Hospira, Inc.; 2007.
46. Nitroglycerin in 5% dextrose injection. Deerfeld, IL: Baxter Healthcare Corporation; 2000.
47. Labetalol hydrochloride injection. Lake Forest, IL: Hospira, Inc.; 2004.
48. Brevibloc (esmolol) premixed injection. Deerfeld, IL: Baxter; 2007.